The Efficacy of the Ribonucleotide Reductase Inhibitor Didox in Preclinical Models of AMLGuerry Cook(Wake Forest University), Timothy S. Pardee(Wake Forest University)PLoS ONENovember 17, 201410.1371/journal.pone.0112619Cited by 8SaveCiteExport RISWatch citationsRelated PapersOverexpression of MN1 Confers Resistance to Chemotherapy, Accelerates Leukemia Onset, and Suppresses p53 and Bim Induction|PLoS ONE|2012|16